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Abstract 
Background: Within the context of combined interventions, malaria vaccine may provide additional value in malaria 
prevention. Stakeholders’ perspectives are thus critical for informed recommendation of the vaccine in Tanzania. This 
paper presents the views of stakeholders with regards to malaria vaccine in 12 Tanzanian districts.
Methods: Quantitative and qualitative methods were employed. A structured questionnaire was administered to 
2123 mothers of under five children. Forty-six in-depth interviews and 12 focus group discussions were conducted 
with teachers, religious leaders, community health workers, health care professionals, and scientists. Quantitative data 
analysis involved frequency distributions and cross tabulations using Chi square test to determine the association 
between malaria vaccine acceptability and independent variables. Qualitative data were analysed thematically.
Results: Overall, 84.2 % of the mothers had perfect acceptance of malaria vaccine. Acceptance varied significantly 
according to religion, occupation, tribe and region (p < 0.001). Ninety two percent reported that they will accept the 
malaria vaccine despite the need to continue using insecticide-treated nets (ITNs), while 88.4 % reported that they 
will accept malaria vaccine even if their children get malaria less often than non-vaccinated children. Qualitative 
results revealed that the positive opinions towards malaria vaccine were due to a need for additional malaria preven-
tion strategies and expectations that the vaccine will reduce visits to the health facility, deaths, malaria episodes and 
treatment-related expenses. Vaccine related questions included its side effects, efficacy, protective duration, composi-
tion, interaction with other medications, provision schedule, availability to the pregnant women, mode of administra-
tion (oral or injection?) and whether a child born of HIV virus or with a chronic illness will be eligible for the vaccine?
Conclusion: Stakeholders had high acceptance and positive opinions towards the combined use of the anticipated 
malaria vaccine and ITNs, and that their acceptance remains high even when the vaccine may not provide full protec-
tion, this is a crucial finding for malaria vaccine policy decisions in Tanzania. An inclusive communication strategy 
should be designed to address the stakeholders’ questions through a process that should engage and be imple-
mented by communities and health care professionals. Social cultural aspects associated with vaccine acceptance 
should be integrated in the communication strategy.
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Background
Malaria remains a major public health concern in sub-
Saharan Africa (SSA). Tanzania is one of the countries 
in which malaria continues to be a significant cause of 
morbidity, mortality and considered as an impediment to 
social economic growth and welfare [1]. According to the 
National Malaria Control Programme (NMCP), 90 % of 
the Tanzanian population are at risk of malaria, resulting 
into 11 million clinical cases per year. The most vulner-
able to malaria are children and pregnant mothers [2]. In 
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Tanzanian mainland, the number of malaria microscopi-
cally-confirmed cases are 1,550,250 and reported deaths 
are 8525 [3]. Despite a declining trend in the number of 
admissions and deaths over the last few years, the coun-
try experiences a marked variation across regions having 
some with high malaria prevalence and others with low 
prevalence. For instance, there are regions with one per-
cent or less and others with more than 30 % [4]. The cur-
rent malaria interventions in Tanzania include malaria 
testing by microscopy and/or rapid diagnostic tests, 
treatment with affordable and effective malaria treat-
ment, such as artemisinin-based combination therapy 
(ACT), protection using long-lasting insecticide-treated 
nets and indoor residual spraying with insecticides, inter-
mittent preventive therapy with sulfadoxine-pyrimeth-
amine for pregnant women [2]. However, challenges 
are also reported on existing malaria interventions with 
regards to resistance of malaria parasites to ACT, as well 
as non-use of mosquito nets [5, 6]. Considering varia-
tions in malaria prevalence and challenges related to the 
existing malaria interventions, more innovative response 
including the vaccines to prevent malaria is likely to 
improve the impact of available interventions.
Vaccines are considered effective interventions in pro-
tecting individuals from infectious diseases and the best 
tool to achieving disease eradication in various contexts 
[7]. The currently most advanced candidate vaccine RTS, 
S/AS01 against Plasmodium falciparum malaria, has 
been tested across several sub-Saharan African coun-
tries including Tanzania. Phase 3 trials showed that dur-
ing 12  months of follow-up, half malaria episodes were 
protected in 5–17  months. One third malaria episodes 
were protected in 6–12  weeks cohort [8]. In infants 
6–12  weeks of age, vaccine efficacy was about 30  % 
against both for clinical and severe malaria [9]. Recent 
study indicates that during 18 months of follow up, vac-
cination of children and young infants with RTS, S/AS01 
prevented many cases of clinical and severe malaria and 
that the vaccination showed the highest impact in regions 
with the highest incidence of malaria [10]. Tanzania with 
other countries in Africa is underway to launch a malaria 
vaccine which is hoped to cut episodes of clinical malaria 
in young children by about half [11]. In the context of the 
current efficacy results a policy recommendation is likely 
to occur paving a way for the implementation of the vac-
cine in countries through their expanded programmes on 
immunization.
Although stakeholders’ (community and professionals) 
voice is imperative before policy endorsement [12]; to 
date, there is limited information regarding their accept-
ance and questions related to the vaccine. Where infor-
mation on the acceptance of the malaria vaccine exists 
[13, 14], it is not incorporated within the context of the 
ongoing malaria interventions and does not highlight 
on whether people may be willing to undertake the vac-
cine even when it is unlikely to provide full protection. 
Moreover, the accounts of contextual aspects that influ-
ence vaccine acceptance are not fully presented. Such 
information is crucial for policy decisions and future 
implementation if recommendation on the vaccine is 
made in the near future. However such information is 
missing in Tanzania despite being one of the country in 
which the RTS, S/AS01 vaccine trial was implemented. 
Experience indicates that it takes time for the interven-
tions to gain public acceptance even after it has been 
licensed due to various factors including community 
acceptance and inadequate prior information that could 
inform the policy makers on what need to be considered 
before the implementation of the intervention [14]. Also, 
the absence of critical data could slow down the decision 
process that policymakers must undertake to determine 
whether or not to introduce a particular intervention 
into their health systems [15]. In addition, lack of com-
munity support due to poor knowledge and perceptions 
made community delay the uptake while others reject 
vaccines. For instance, it existed when Polio vaccination 
programme was delayed in northern Nigeria [16]. There-
fore, it is crucial that community perceptions are under-
stood and used to highlight any community-based issues 
that need to be considered during policy deliberation and 
intervention planning [17].
Within the context of planning for a vaccine to be 
used alongside existing malaria control methods, moth-
ers of children under five and other stakeholders (teach-
ers, religious leaders, community health workers, health 
care professionals and scientists) were interviewed to 
assess their perceptions on malaria and acceptance of the 
malaria vaccine.
The following were the specific objectives:
  • To determine stakeholders’ acceptance of the antici-
pated malaria vaccine and the associated factors.
  • To assess stakeholders’ perception and attitude 
towards the vaccines.
  • To explore stakeholders’ expectations from the antic-
ipated malaria vaccine.
  • To explore stakeholders’ questions with regards to 
the anticipated malaria vaccine.
We hope that the study findings may assist the policy 
makers in Tanzania to make informed decisions on the 
introduction of malaria vaccine in line with other existing 
malaria intervention strategies [15]. The data may also 
inform the design of the communication strategy and 
guide the country’s programmers on the issues to be con-
sidered before the actual implementation of the vaccine.
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Methods
Overall study design
A cross sectional study that involved quantitative and 
qualitative methods was conducted. The study was imple-
mented between May and June 2013 in twelve districts 
of Tanzanian mainland (Table  1). The mixed method 
approach aimed at triangulating the methods and find-
ings for completeness of the data [18]. The participating 
districts were from areas where phase II and III RTS, S 
malaria vaccine trial had not been implemented. This was 
done purposely to minimize bias of opinion with regards 
to acceptance of malaria vaccine. The districts were from 
the northern, eastern, western, central and southern parts 
of the country for enhancing the representativeness of 
voices from communities of diverse background since 
the future malaria vaccine may not only be introduced in 
trial sites. Malaria in the study regions ranges from 1 % in 
Arusha to more than 20 % in Lindi and Mtwara [1]. In the 
country, EPI coverage is high but varies across regions hav-
ing the highest coverage in Arusha (100 %) and the lowest 
coverage in Kagera (57 %) [19]. The health care system in 
Tanzania is composed of the public hospitals and the pri-
vate hospitals. Hospitals are the highest level of access to 
care and the dispensary being the lowest level. However, at 
the dispensaries is where the majority of people in urban 
and rural communities access their health care.
Qualitative methods
Design and setting
Using qualitative approach, the study employed parallel 
individual interviews (IDIs) and focus groups discussions 
(FGDs). Qualitative participants were from some of the 
study sites where the quantitative study was conducted 
including participants from Mwanza (Ilemela district), 
Mbeya (Ileje district) and Arusha (Ngorongoro district). 
Addition participants were from Morogoro and Dar es 
Salaam regions. Preference to conduct qualitative study 
in these sites was based on the convenience and cost.
Study population and recruitment
Forty six IDIs and 12 FGDs were conducted. The IDI par-
ticipants comprised of primary school teachers, religious 
leaders, community health workers, health care profes-
sionals, and scientists. The scientists who participated 
in the discussion were from various professional back-
grounds (sociologists, medical doctors, public health, 
epidemiologists) excluding those who were participating 
in the clinical trials. FGDs were carried on with men and 
women in the respective study sites. The FGDs allowed 
insights into general group norms on the vaccines and 
capturing varied views and questions with regards to the 
anticipated malaria vaccine. The IDIs involved individu-
als who were believed to be capable of providing personal 
opinions about malaria and the anticipated malaria vac-
cine. The participants in the local communities were 
purposively [20] selected by the assistance of the commu-
nity leaders believed to be influential in decisions about 
health-seeking practice in their families and community 
at large. Scientists were recruited from various institu-
tions both public and private. Selection of the scientists 
was mostly based on the convenience and availability of 
the individuals in their institutions. The health care pro-
fessionals were recruited based on their assimilation with 
child care services i.e. working in the reproductive health 
unit and paediatric care.
Data collection
Focus group guide with open ended questions was used 
to collect FGD data, while a semi structured topic list 
was used to collect IDI data. Both tools addressed similar 
topics directly designed to address specific study objec-
tives. The tools were adjusted according to the best fit 
of the study audience. Main topics included: perception 
about malaria status, perception about malaria vaccine, 
expectations from malaria vaccines, preferred modality 
of providing malaria vaccine and questions with regards 
to malaria vaccine. IDI and FGD tools were piloted for 
practicability. Experienced research assistants conducted 
the IDIs and FGDs. Prior to data collection experi-
enced social scientists (SM, AK) provided training to the 
research assistants. The training familiarized them with 
the study objectives, status of malaria vaccine research, 
interview procedures and ethical aspects. The FGDs were 
made of up to 7–9 participants and composed of a mod-
erator who facilitated the discussion and a note taker 
who assisted in taking notes. Both discussions and inter-
views were conducted in a place convenient to the study 
participants. To enhance freedom of discussion, women 
and men had separate discussion groups. The discussion 
Table 1 Study regions and the selected districts
Regions Districts
Arusha Ngorongoro
Tanga Handeni
Kagera Ngara
Pwani Kisarawe
Mtwara Newala
Mbeya Ileje
Mara Serengeti
Lindi Lindi rural
Mwanza Ilemela
Morogoro Morogoro Municipal/Kilombero
Dar es Salaam Kinondoni
Dodoma Dodoma Municipal
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sessions were conducted in Kiswahili, a Tanzania national 
language which is well understood and used commonly 
in the study area. Subject to participants’ consent some 
data from interviews with communities were audio-taped 
but other data was put in the expanded notes [21]. The 
interviews and discussions lasted for 1 h and 30 min on 
average.
Data analysis
Audio-recorded data was transcribed verbatim for analy-
sis. The transcripts and expanded notes were checked 
for completeness and accuracy. Two social scientists 
(SA and AK) experienced in qualitative studies indepen-
dently reviewed the transcripts to identify the relevant 
patterns and later the patterns were grouped into main 
themes. N-VIVO program [22] assisted in the display of 
participants expressions and the coding process. Consid-
ering the views of various stakeholders, a constant com-
parison approach was employed to compare themes that 
emerged from these analytic procedures [23]. To con-
solidate results, the identified themes and categories were 
shared in a malaria vaccine working groups and during 
the national stakeholders’ meeting.
The stakeholders from immunization department in 
Tanzania and others discussed the findings and the con-
sensus was reached about the interpretation of the results. 
All data were analysed in the Kiswahili but relevant quotes 
were translated into English for the purpose of this paper.
Quantitative methods
The study involved face to face household interviews with 
women aged 18  years and above, who had at least one 
child under 5 years. Quantitative study was employed to 
estimate level of acceptance of the malaria vaccine and 
preferred modality of providing malaria vaccine. The 
structured questionnaire was used to interview the eligi-
ble mothers. Before the interviews, the tools were piloted 
and later necessary changes were adopted in the tools.
A multi-stage random sampling was used to select the 
households in the specific study areas. At first the coun-
try was stratified based on regions, one region was ran-
domly selected from which a list of districts was sought 
and then one district was randomly selected from the list 
of districts, (excluding the two districts that have been 
involved in malaria vaccine trial that is Bagamoyo and 
Korogwe), followed by village, and lastly household. The 
sample size was calculated based on simple random sam-
pling given by the following formula and values attrib-
uted to parameters:
n =
Z2p(1− p)N
d2(N−1)+Z
2p(1−p)
n =  sample size; z–score, which is the number of stand-
ard deviations from the mean. At 95  % confidence level, 
z = 1.96; p = prevalence of malaria (assumed to be 50 %); 
d = absolute precision required (1 %); N = population size 
(different according to the region, ranging from 188 to 332).
Thereafter, the sample size from simple random sample 
was multiplied by design effect to take into account the 
clustering effect. The design effect is given by: 
where, ρ is a cluster correlation. The sample size was 
required to detect 50  % proportion on perception of 
malaria vaccine. The sample size calculation was to give 
idea of how many individuals were deemed to be inter-
viewed from each study district. Prior to data collection, 
the research team received orientation on the purpose of 
the study, reminded about ethical aspects and review of 
the questions. Electronic devises (tablets) were used to col-
lect information during the interviews, and later the infor-
mation was synchronized into the field computers. Quality 
check and errors were carried out in the field and prompt 
feedback was provided to the field supervisors and later to 
the research assistants for corrective measures.
All the quantitative data were managed and analysed 
using STATA 11 Software (Stata corp, USA). Data analy-
sis was performed as both one-way frequency distribu-
tions and cross tabulations of various outcomes against 
selected independent variables. In the latter case, Chi 
Square (χ2) was used to test the degree of association 
between each pair of categorical variables involved in a 
cross-tabulation. The significance was determined at 
p  ≤  0.05. Acceptability of the anticipated malaria vac-
cine was the main variable and was defined by three 
questions;
(A) Researchers are working to develop a malaria vac-
cine, which will have the possibility of reducing the 
recurrence of malaria among children. If the malaria 
vaccine becomes available will you be willing for 
your child to receive that malaria vaccine?
(B)  Malaria vaccine may cause discomfort similar to 
other childhood vaccines will you agree or disagree 
that your child still get vaccinated?
(C) Even though a child is vaccinated, s/he will still have 
to use ITNs and seek treatment if s/he has fever. 
Will you agree that your child get vaccinated?
Frequency distribution of responses in each of these 
questions (A, B and C) was performed.
Then bivariate analysis of each question, independ-
ent of the other, was conducted to assess how each 
of these outcomes was related to background and 
Def = 1+
(
Average population per cluster − 1
)
× ρ
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non-background characteristics of the participants, such 
as age, education, religion and region. Finally, these vari-
ables were combined to form a single powerful indicator 
of acceptability, such that: 
Acceptance of malaria vaccine =


PERFECT if A = YES and B = YES and C = YES
PARTIAL if YES to any one or two but not all of the A, B and C
NO if A �= YES
Perception and attitude towards vaccines
Qualitative participants (mostly women) possessed a 
positive opinion towards vaccines. They were in the opin-
ion that the vaccines are important for the reduction of 
Ethical aspects
The study was approved by the ethical review board of 
the Ifakara Health Institute (IHI-IRB). Prior to inter-
views, local authorities were contacted and asked for 
permission. Written consent to approach the study com-
munities was obtained. Verbal and written informed con-
sents were obtained from all study participants through 
which participants were assured of anonymity and confi-
dentiality of information.
Results
Since the study was a mixed method design, results are tri-
angulated for the purpose of elaboration and completeness. 
Results are presented in general themes emanated from 
the study objectives. Qualitative findings are not presented 
according to study groups due to observed convergence of 
views and opinions with regards study phenomenon.
Characteristics of study respondents
Out of a sample size of 2124, a total of 2123 mothers with 
children under five from nine districts participated in the 
study. Of the 2123 mothers, 70 % were in the age range 
of 20 and 34 years. A majority of mothers (84 %) were in 
marital relations. Slightly more than one third (34.7 %) of 
the participants had more than three children. The study 
population was relatively literate with only 19.4  % of 
respondents who had never attended school, whilst about 
69.4 % had attained primary school and 11 % had second-
ary education. A majority (70.4  %) of respondents were 
farmers. About 56.2  % of respondents were Christians 
and 40.9 % were Muslims (Table 2).
Qualitative participants composed of 21 health care 
professionals (18 health care providers and four pae-
diatricians), six teachers, four religious leaders and six 
community health workers. Twelve more IDIs were con-
ducted with scientists from various institutions in Dar es 
Salaam (Table 3). FGDs were carried on with six groups 
of women and six groups of men. Most of the FGD and 
IDI participants were of age 25 and 50. Non-professional 
participants were mostly farmers and petty trade deal-
ers. Most of them had attained primary school level. The 
majority of the professionals, such as nurses and teach-
ers, were of secondary school and high school levels.
disease severity, reduced cost of treatment and disease 
prevention.
One female participant expressed her opinion that vac-
cine would reduce the severity of disease:
“I know that when a child gets vaccinated he will be 
protected from diseases. Even if the disease comes, it 
will not be very much severe as compared to if the 
child has not completely received a vaccine” (FGD, 
Female_04).
Another female participant was in the opinion that vac-
cine is important for prevention of diseases:
“Just like what the experts says “it is better to pre-
vent than to cure” then I think vaccination is impor-
tant as it helps to prevent a child from diseases and 
reduces treatment costs because during treatment 
you use much cost to treat the child unlike when 
the child is protected (with the vaccine)” (FGD, 
Female_05).
Similarly in the quantitative study, the majority (90.1 %) 
of mothers reported that there is a benefit associated 
with vaccination (Fig. 1). Also, about 97.6 % agreed with 
the statement that ‘I prefer my child to receive all the vac-
cines’ (Table 4).
Acceptance of malaria vaccine and the associated reasons
Most of the opinions of the qualitative participants 
reflected a positive acceptance towards the anticipated 
malaria vaccine. The main consensus was that malaria 
vaccine is important since malaria is still a common dis-
ease among children under five.
One of the paediatricians provided his view that 
malaria vaccine need to be provided since more strate-
gies are needed to fight malaria:
“I think malaria problem is still there and more 
weapons are needed in making sure that it is pre-
vented, vaccine is one of the weapon, but if it’s safe 
for the users” (IDI, Paediatrician _05).
Another participant was in the opinion that malaria 
still affects children and hence a need to introduce 
malaria vaccine:
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“Malaria vaccine should be introduced due to the 
burden of malaria especially for young children” 
(IDI, Nurse, RCH_06).
A male participant thought that malaria vaccine is 
needed because the mosquito nets cannot provide full 
protection from mosquitoes:
“I think we need malaria vaccine since we are not 
always covered by the mosquito nets. Look at where 
we are now, we have stayed for almost one hour and 
the mosquito nets are inside our houses on the beds. 
Probably the mosquitoes might have already bitten 
the child. Therefore, we cannot totally depend on the 
mosquito nets …” (FGD, Male_ 05).
Table 3 Summary of the IDIs and FGDs participants
Further details Total number 
of participants
IDIs
 Health care professionals
  Nurses From public health facilities 
and private health facilities
12
  Paediatricians From public health facilities 3
  Paediatricians From private health facilities 3
  Teachers From rural community 6
  Religious leaders From Muslim community 2
  Religious leaders From Christian community 2
  Community  
health workers
From rural community 6
  Scientists From sociological back-
ground
3
  Scientists From medical background 3
  Elites From government and  
private institutions
6
  Total 45
 FGDs
  Women From rural community 6
  Men From rural community 6
  Total 12
Fig. 1 Percent distribution of respondents that believe that there are 
benefits related to under-five child vaccination (n = 2123)
Table 2 Characteristics of the respondents in 2013 house-
hold survey (n = 2123)
Characteristics Number of  
respondents (n)
Percent 
(%)
Overall 2123 100.0
 Age (years)
  <20 143 6.7
  20–34 1499 70.6
  >34 481 22.7
  Mean = 28.9 ± 7.6, min = 15.0, max = 65.0 – –
 Marital status
  Currently married 1793 84.5
  Ever married (currently divorced/widowed) 143 6.7
  Single 187 8.8
 Education
  Never been to school 412 19.4
  Primary 1473 69.4
  Secondary+ 238 11.2
 Parity (number of children)
  1 537 25.3
  2 473 22.3
  3 376 17.7
  4+ 737 34.7
 Occupation
  Farmer/other 1495 70.4
  Business (petty vender, tailoring etc) 355 16.7
  Housekeeper/no job 215 10.1
  Civil servant 58 2.7
 Religion
  Islam 868 40.9
  Christian 1192 56.2
  Other 63 3.0
 Tribe
  Kurya 313 14.7
  Makonde 272 12.8
  Hangaza 206 9.7
  Zigua 204 9.6
  Zaramo 140 6.6
  Ndali 129 6.1
  Sukuma 120 5.7
  Othersa 739 34.8
 Region (district)
  Arusha (Ngorongoro) 280 13.2
  Kagera (Ngara) 331 15.6
  Lindi (Lindi rural) 183 8.6
  Mara (Serengeti) 286 13.5
  Mbeya (Ileje) 188 8.9
  Mtwara (Newala) 193 9.1
  Mwanza (Ilemela) 235 11.1
  Pwani (Kisarawe) 190 9.0
  Tanga (Handeni) 237 11.2
a  Sonjo, Mwela, Yao, Iraki, Chagga, Ha, Masai, Haya, Zigua, Sambaa etc
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The quantitative results revealed that the majority 
(84.2 %) of the participants indicated a perfect acceptance 
of malaria vaccine, 11.9  % had partial acceptance while 
3.9 % had no acceptance of the vaccine (Table 5). Occu-
pation, tribe, religion, and regions attained a statistical 
significance with the perfect acceptance of the malaria 
vaccine (p < 0.001), with farmers, Christians, members of 
the tribe Hangaza and households in the Kagera region 
presenting higher acceptance levels.
Expectations from malaria vaccine
The common expectations from the malaria vaccine by 
most participants comprised a view that malaria vac-
cine will lessen the malaria episodes, frequent visits to 
the hospital due to malaria, the number of deaths and 
that the overall burden of malaria among children will be 
reduced.
“My expectations is that if malaria vaccine will 
work, it will help reduce the hassle we get of having 
frequent malaria, you will find a child going back 
to hospital even four times in a month” (FGD, Male 
_03).
“The expectations of most people will be that the 
malaria vaccine will completely eradicate malaria, 
because the children will have protection…and so 
malaria will finish…” (FGD, Female_05).
“The health care providers will feel very proud to 
have this additional vaccine on top of the existing 
ones since we hope it will succeed in reducing the 
mortality rate especially for children under 5 years” 
(Nurse, RCH_05).
“Most mothers will definitely take their kids for vac-
cination since the costs of treatment nowadays is 
very high” (Teacher_02).
Acceptance of malaria vaccine in the context of ITN use
The majority (92.5 %) reported that they will be ready to 
take their children for malaria vaccine despite their obli-
gation to use ITNs and seek treatment when the child has 
fever. There were differences in the level of acceptance 
across regions, religion and tribe. The Mbeya region was 
more likely to indicate acceptance comparatively to other 
study regions (p = 0001) (Table 6).
Acceptance of malaria vaccine in the context of partial 
protection
Participants were asked to provide their views on how 
they think about accepting the forthcoming malaria 
vaccine despite that their children will get malaria less 
often than those who don’t get the vaccine. Most par-
ticipants views consistently indicated a willingness to 
uptake malaria vaccine in the context of its partial pro-
tection due to their concern with the burden of malaria 
and the view that the less the episodes the less the cost of 
treatment.
“This malaria vaccine need to be introduced because 
it will reduce the magnitude of malaria, even if it 
reduces to some extent, it is still important, because 
if a child gets malaria less frequently different from 
now, the costs of treatment will reduce…” (IDI, Reli-
gious leader_02).
“If efficacy is 50 % is fine as long as you have helped 
the person by reducing the episodes. This will help 
to enhance immunity” (IDI, Health professional lec-
turer_04).
“Vaccine would be the best solution, even if it is par-
tially protected then should be introduced. It should 
go parallel with other strategies to be more effective.” 
(IDI_Paediatrician_3).
“…. even with existing vaccines, still the children get 
sick but not as much as those who did not get vac-
cine at all” (Teacher_03).
The views of the qualitative participants converged 
with the quantitative data which indicated that the 
majority of mothers (88.4  %) reported that they will be 
Table 4 Perception towards  vaccine: percent distribution 
of  respondents that  AGREE with  the listed statements 
by region (n = 2123)
Number 
of respond-
ents
% Stated that …
I prefer my 
child to  
have all  
vaccinations
I prefer my 
child to have 
certain  
vaccinations
I prefer my  
child not 
to be  
vaccinated 
at all
Overall 2123 97.6 0.7 0.1
 Region
  Arusha 280 98.2 1.1 0.4
  Kagera 331 98.8 0.0 0.0
  Lindi 183 97.3 1.6 0.0
  Mara 286 99.0 1.4 0.0
  Mbeya 188 100.0 0.0 0.0
  Mtwara 193 97.9 0.0 0.0
  Mwanza 235 98.7 0.9 0.0
  Pwani 190 91.6 0.0 0.0
  Tanga 237 94.9 0.8 0.0
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Table 5 Degree of malaria vaccine acceptability by various characteristics (n = 2123)
a  Sonjo, Mwela, Yao, Iraki, Chagga, Ha, Masai, Haya, Sambaa etc
Characteristics Total number 
of respondents
Degree of acceptability (%) P value
Perfect acceptance Partial acceptance No acceptance
Overall 2123 84.2 11.9 3.9 ‒
 Age (years)
  <20 143 83.9 14.0 2.1 0.466
  20–34 1499 83.6 12.3 4.1
  >34 481 86.1 10.2 3.7
 Marital status
  Currently married 1793 84.5 11.4 4.1 0.149
  Ever married (currently divorced/widowed) 143 79.7 18.2 2.1
  Single 187 84.5 11.8 3.7
 Education
  Never been to school 412 87.4 10.2 2.5 0.136
  Primary 1473 83.9 12.0 4.1
  Secondary+ 238 80.3 14.3 5.5
 Parity (number of children)
  1 537 81.8 14.3 3.9 <0.169
  2 473 82.0 13.5 4.4
  3 376 85.6 10.1 4.3
  4+ 737 86.6 10.0 3.4
 Occupation
  Farmer/other 1495 86.1 10.5 3.4 <0.001
  Business (petty vender, tailoring etc) 355 81.1 14.7 4.2
  Housekeeper/no job 215 77.7 17.7 4.7
  Civil servant 58 77.6 10.3 12.1
 Religion
  Islam 868 79.7 13.5 6.8 <0.001
  Christian 1192 87.3 10.8 1.9
  Other 63 87.3 11.1 1.6
 Tribe
  Kurya 313 87.5 10.9 1.6 <0.001
  Makonde 272 79.8 16.5 3.7
  Hangaza 206 93.7 4.9 1.5
  Zigua 204 90.2 6.4 3.4
  Zaramo 140 76.4 10.0 13.6
  Ndali 129 90.7 8.5 0.8
  Sukuma 120 80.8 15.8 3.3
  Othersa 739 80.9 14.5 4.6
 Region (district)
  Arusha (Ngorongoro) 280 80.0 16.8 3.2 <0.001
  Kagera (Ngara) 331 93.4 5.1 1.5
  Lindi (Lindi rural) 183 78.1 16.4 5.5
  Mara (Serengeti) 286 86.7 11.2 2.1
  Mbeya (Ileje) 188 90.4 9.0 0.5
  Mtwara (Newala) 193 79.8 16.1 4.2
  Mwanza (Ilemela) 235 81.3 16.2 2.6
  Pwani (Kisarawe) 190 72.1 15.8 12.1
  Tanga (Handeni) 237 89.0 4.6 6.3
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comfortable that their children receive malaria vaccine 
despite that they will still get malaria less often than 
those who don’t get the vaccine. Age of mothers, religion, 
region and tribes were statistically significantly associ-
ated with the acceptance of partial protection of malaria 
vaccine (Table 7).
Questions regarding the anticipated malaria vaccines
Despite a positive attitude towards the anticipated 
malaria vaccine, most participants had various questions 
with regards to the vaccine. However, there appeared to 
be similarities with regards to the questions asked by the 
communities and those asked by other professions. Most 
questions were mostly related to the side effects of the 
vaccine and the government response to them, efficacy, 
protective duration, composition, interaction with other 
medications, relation of vaccine schedule with existing 
EPI schedule, availability of the vaccine to the pregnant 
women, mode of administration (oral or injection?) and 
whether child born of HIV virus or with a chronic illness 
will be eligible for the vaccine? (Fig. 2).
Discussion
The study findings suggest that stakeholders have a posi-
tive attitude towards the anticipated malaria vaccine and 
that their acceptance of the vaccine remains high despite 
the fact that it would be used parallel with other existing 
intervention strategies. Interestingly, the acceptance level 
also remains significant though the malaria vaccine is less 
likely to provide full protection. This outcome could be 
a reflection of how malaria is seriously perceived in the 
communities being studied. Furthermore, they may be 
willing to accept the new malaria interventions as long 
as they will (to some extent) contribute to the reduction 
of malaria, especially among children. Similarly, a study 
in Kenya also found that participants understood that 
malaria is a serious problem that no single tool can be 
used to combat it, which influences their acceptance of 
malaria vaccine [14]. Acceptance of malaria vaccine was 
also observed in studies conducted in Ghana [13] where 
the views of various professions and communities also 
reflected a positive opinion towards the introduction of 
malaria vaccine as a preventive tool. The study finding 
Table 6 Percent distribution of  respondents ready to  get 
their children vaccinated with malaria vaccine despite the 
fact that  even though  a child is vaccinated, s/he will still 
have to  use ITNs and  seek treatment if  s/he has fever; 
by various characteristics (n = 2123)
Characteristics Total number 
of respondents
% Ready P value
Overall 2123 92.5 ‒
 Age (years)
  <20 143 93.7 0.798
  20–34 1499 92.3
  >34 481 92.7
 Marital status
  Currently married 1793 92.5 0.742
  Ever married (cur-
rently divorced/
widowed)
143 90.9
  Single 187 93.1
 Education
  Never been to school 412 92.5 0.962
  Primary 1473 92.5
  Secondary+ 238 92.0
 Parity (number of children)
  1 537 93.1 0.446
  2 473 90.9
  3 376 92.0
  4+ 737 93.2
 Occupation
  Farmer/other 1495 93.1 0.125
  Business (petty 
vender, tailoring 
etc)
355 90.7
  Housekeeper/no job 215 92.6
  Civil servant 58 86.2
 Religion
  Islam 868 88.5 <0.001
  Christian 1192 95.1
  Other 63 96.8
 Tribe
  Kurya 313 94.6 <0.001
  Makonde 272 91.2
  Hangaza 206 96.1
  Zigua 204 94.1
  Zaramo 140 82.1
  Ndali 129 99.2
  Sukuma 120 92.5
  Othersa 739 91.3
 Region (district)
  Arusha (Ngorongoro) 280 92.1 <0.001
  Kagera (Ngara) 331 96.7
  Lindi (Lindi rural) 183 88.5
  Mara (Serengeti) 286 93.7
  Mbeya (Ileje) 188 99.5
a  Sonjo, Mwela, Yao, Iraki, Chagga, Ha, Masai, Haya, Sambaa etc
Characteristics Total number 
of respondents
% Ready P value
  Mtwara (Newala) 193 90.7
  Mwanza (Ilemela) 235 93.6
  Pwani (Kisarawe) 190 81.1
  Tanga (Handeni) 237 92.4
Table 6 continued
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that stakeholders would still maintain the acceptance of 
malaria vaccine in the context of existing malaria inter-
vention strategies is in line with the overall idea of intro-
ducing the vaccine which is not meant to replace the 
existing malaria interventions but rather to compliment 
it [11].
In this study, social cultural aspects emerged as fac-
tors associated with the acceptance of malaria vaccine. 
These factors include religion (Christians were more 
willing than Muslims to accept the vaccine), religion 
(Ndali tribe was less willing to accept the vaccine than 
the other tribes), and civil servants were more willing 
to accept the vaccine than the farmers. This finding cor-
roborates with evidence from other countries in Africa 
[24] and elsewhere [25] where religion and ethnicity 
were found to influence health care utilization. Specific 
evidence also indicates that religion and ethnicity are 
associated with vaccine awareness and acceptance i.e 
measles vaccine and Human Papillomavirus (HPV) [25, 
26].
The differences in vaccine acceptance based on reli-
gion, ethnicity and occupation as observed in this study 
could also reflect that people’s values, preferences and 
expectations would sometimes constrain their accept-
ance of a particular health care programme. These could 
originate from the culture in which the social interac-
tion is taking place, which in turn govern their decisions 
about how they should pursue a recommended health 
intervention [27]. Although other studies have found that 
the quality of care i.e. congestion, delays, and the per-
ceived attitudes of the health care providers [14], access 
to services, reliability of services fear of side effects, and 
parental beliefs and conflicting priorities [28] constraints 
immunization services, this study shows that in addition 
to individual and health system factors, the social cultural 
aspects may play a significant role in influencing the dif-
ferential acceptance of vaccination programmes. This is 
central in this paper, and it lends support to the views of 
other researchers that people may not automatically use a 
health intervention once introduced [14], and in the con-
text of a vaccine, if the known barriers are not addressed 
may lead to under-utilization of immunization coverage 
[16, 29].
Table 7 Percent distribution of  respondents that  ans-
wered “YES” to the question “If your child receives malaria 
vaccine, and  still gets malaria but  less often than  those 
who don’t get vaccine, will you be comfortable with that?”; 
by various characteristics (n = 2123)
Characteristics Total number_ 
of respondents
% That would  
be comfortable
P value
Overall 2123 88.4 –
 Age (years)
  <20 143 83.2 0.010
  20-34 1499 87.9
  ≥34 481 91.7
 Marital status
  Currently married 1793 88.7 0.559
  Ever married (currently 
divorced/widowed)
143 86.7
  Single 187 86.6
 Education
  Never been to school 412 87.9 0.863
  Primary 1473 88.7
  Secondary+ 238 87.8
 Parity (number of children)
  1 537 86.2 0.253
  2 473 88.2
  3 376 89.9
  4+ 737 89.4
 Occupation
  Farmer/other 1495 88.8 0.293
  Business (petty vender, 
tailoring etc)
355 88.5
  Housekeeper/no job 215 84.7
  Civil servant 58 91.4
 Religion
  Islam 868 85.0 <0.001
  Christian 1192 90.7
  Other 63 92.1
 Tribe
  Kurya 313 92.3 <0.001
  Makonde 272 87.5
  Hangaza 206 92.2
  Zigua 204 92.2
  Zaramo 140 74.3
  Ndali 129 93.0
  Sukuma 120 83.3
  Othersa 739 87.7
 Region (district)
  Arusha (Ngorongoro) 280 92.5 <0.001
  Kagera (Ngara) 331 90.6
  Lindi (Lindi rural) 183 84.2
  Mara (Serengeti) 286 89.9
  Mbeya (Ileje) 188 93.1
  Mtwara (Newala) 193 88.6
a  Sonjo, Mwela, Yao, Iraki, Chagga, Ha, Masai, Haya, Sambaa etc
Characteristics Total number_ 
of respondents
% That would  
be comfortable
P value
  Mwanza (Ilemela) 235 89.4
  Pwani (Kisarawe) 190 72.6
  Tanga (Handeni) 237 89.9
Table 7 continued
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Currently there is a strong recognition globally that 
health is socially determined and that social-structural 
aspects are responsible for health inequity. As found in 
this study, religion and ethnicity may play a significant 
role towards inequity in immunization coverage. Health 
inequity is known to be a set back to the wider health 
development, and this could be addressed by examin-
ing the wider social and structural aspects that increase 
vulnerability to diseases [30–33]. Evidence in Nigeria 
indicates that the community tailored interventions have 
proven to be effective in increasing the utilization of polio 
vaccination [34]. As such, the public health communica-
tion strategy that seek to promote the available immuni-
zation services as well as the anticipated malaria vaccine 
could be made effective if tailored within the broader 
social aspirations and cultural differences existing in the 
locally contextualized environment.
This study also found that the community and 
other professionals have multiple expectations and 
questions that relate to the anticipated malaria vac-
cine. It is important that the Tanzanian Immunization 
Department, malaria vaccine initiative, and other 
malaria stakeholders clarifies the questions and expec-
tations prior to or parallel with the introduction of the 
malaria vaccine and provide the correct knowledge 
about the added value of malaria vaccine in lay man’s 
language to avoid any misconceptions about the antici-
pated malaria vaccine. The voices of communities and 
that of the health care professionals are important and 
should be considered for better informed decisions, pol-
icy recommendation, planning and designing of a com-
munication strategy. Failure to account for community’s 
prior information that could enlighten policy makers on 
what is needed to be considered before the implementa-
tion of the intervention was found as one of the factors 
that could delay the public acceptance of the proposed 
intervention [14].
Conclusions
Understanding stakeholders’ acceptability and perspec-
tives regarding the anticipated malaria vaccine in the con-
text of other ongoing malaria interventions is crucial for 
Communities Professions 
1. How many times will the children need to 
receive the vaccine? 
2. Will the child born of HIV virus or with a 
chronic illness be allowed to receive a 
malaria vaccine?
3. Will the vaccine be available also for 
pregnant women?
4. What will be the schedule of providing a 
vaccine? Is it when the child gets malaria 
or…?.
5. The vaccine will be provided for which age?
6. How long will the vaccine take to expire in 
the body or will it be a lifelong vaccine?
7. Will the vaccine really protect children and 
not bring harm?
8. Will the child need to continue using a 
mosquito net or the vaccine would have 
protected the child?
9. On what form will the vaccine be provided? 
Is it in liquid or injection?
10. If the vaccine becomes poisonous to children 
what will the government do to help the 
child?
1. What will be the side effects of the vaccine?
2. Will the new clinic cards be issued? Or the 
information will be integrated within the existing 
cards?
3. How will the vaccine interact with other 
medications?
4. What will the providers do if the vaccines fail to 
work?
5. Will the vaccine have a booster dose?
6. Will it be given separately or in combination with 
the existing vaccines?
7. Will the vaccine completely protect children from 
malaria?
8. Will the nurses be trained for the new vaccine?
9. Will the vaccine be provided to adults?
11. Which type of plasmodium does the vaccine target?
12. What will be the mode of administration? (given in 
powder or liquid form?)
13. What will be the extent of it’s risk? 
14. What does the malaria vaccine compose?
15. What are the associated side effects?
Fig. 2 The common questions with regards to malaria vaccines by communities and professions
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appropriate policy decisions in Tanzania. Stakeholders’ 
high acceptability of the anticipated malaria vaccine, even 
when it is less likely to provide full protection may reflect 
the extent to which malaria interventions, are needed in 
the study areas. However the questions raised by the com-
munities reflect the need to clarify some misconceptions 
and provision of correct knowledge regarding the vaccine. 
The optimal acceptance and utilization of the anticipated 
malaria vaccine may require addressing of the social cultural 
aspects that could impede the utilization of the vaccine.
Key messages and recommendations
The fact that the views of various community groups reflect 
a willingness to undertake malaria vaccine parallel with 
the existing malaria intervention strategies (such as ITNs) 
could be one of the strengths within the National Malaria 
Control Strategy in Tanzania. This aspect may need to be 
emphasized during the implementation phase of malaria 
vaccine, since the vaccine may not provide full protection. 
Communities are also ready to accept a partial efficacy 
malaria vaccine, which may be useful in guiding policy rec-
ommendations toward the vaccine in the country.
Although stakeholders possess a positive opinion 
towards the anticipated malaria vaccine there is much on 
which the Tanzanian Immunization Department, malaria 
vaccine initiative, and other malaria stakeholders, need to 
undertake for optimal acceptance and utilization of the 
vaccine. Based on the findings the following  recommen-
dations can be made:
  • The communication strategy should clarify the ques-
tions and expectations raised by stakeholders prior to 
or parallel with the introduction of the malaria vac-
cine in lay man’s language to avoid any misconcep-
tions about the anticipated malaria vaccine.
  • Issues on religion, ethnicity, occupation and region 
should be considered for the designing of culturally 
based interventions to increase the acceptability and 
effectiveness of vaccine programmes.
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